Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

SHAPE and I-ELCAP Announce 1st Conference on Integrating Heart and Lung Screening Using Low-Dose CT to be Held September 19-21, 2024 at the New York Academy of Medicine


News provided by

SHAPE

Sep 14, 2024, 19:52 ET

Share this article

Share toX

Share this article

Share toX

Dr. Valentin Fuster and Dr. Robert Harrington help open the way to integrating early detection of heart and lung disease.
Dr. Valentin Fuster and Dr. Robert Harrington help open the way to integrating early detection of heart and lung disease.

A Groundbreaking Step in Fighting the Nation's Top Killers: Heart Disease and Lung Cancer

NEW YORK, Sept. 14, 2024 /PRNewswire-PRWeb/ -- The Society for Heart Attack Prevention and Eradication (SHAPE) and the International Early Lung Cancer Action Program (I-ELCAP) are proud to announce the inaugural conference on integrating heart and lung screening using low-dose computed tomography (CT). This pioneering event will take place on September 19-21, 2024, bringing together leading experts to address the critical intersection of heart disease and lung cancer, the first and second leading causes of death in the United States. This pioneering conference will be held in conjunction with the 46th International Conference on Screening for Lung Cancer and the 14th Conference on Early Lung Cancer Research on Treatment (IELCART).

The conference agenda features discussions from top researchers, clinicians, and healthcare innovators who aim to revolutionize early detection of high-risk asymptomatic patients by combining heart and lung screenings into a widely available single low-dose CT exam. This approach holds the potential to save countless lives by identifying individuals at risk of preventable death, i.e. before heart attacks or advanced-stage lung cancer take hold.

"To address the rising burden of cardiovascular disease and lung cancer, new preventive strategies are needed," said Dr. Robert Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine who is the conference's keynote speaker

Post this

"I-ELCAP pioneered screening for lung cancer over 30 years ago and ever since our group has proudly saved countless lives from late-stage fatal lung cancer," said Dr. Claudia Henschke, I-ELCAP founder, and Professor of Radiology, Icahn School of Medicine at Mount Sinai. "Now in collaboration with SHAPE, we're aiming to reduce preventable death both from heart attacks and lung cancer," she added.

"Both heart disease and lung cancer are silent killers that often progress without symptoms until it's too late," said Dr. Morteza Naghavi, founder of SHAPE and president of HeartLung.AI. "This conference is a pioneering step toward transforming preventive care for the number 1 and 2 causes of death in most countries," Dr. Naghavi added.

Approximately 238,340 people were diagnosed with lung cancer in 2023 in the U.S. and about 127,070 American lives were lost to lung cancer in 2023. The overall 5-year survival rate for lung cancer is about 25% and is mainly due to diagnosis in late stages, whereas the 5-year survival rate for lung cancer screening population is over 90%.

Approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD). Globally, cardiovascular diseases account for approximately 20 million deaths per year. In the United States, the most recent data shows 702,880 deaths from heart disease per year.

"To address the rising burden of cardiovascular disease and lung cancer, new preventive strategies are needed," said Dr. Robert Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine who is the conference's keynote speaker. "I'm pleased to take part in this initiative and look forward to its promising impacts on public health in the future."

The conference aims to set the stage for broader implementation of this dual screening methodology than currently recommended in the national guidelines. This could significantly enhance preventive care in at-risk populations. For example, over 20,000 patients diagnosed with lung cancer in the U.S. are non-smokers and therefore do not qualify for low-dose CT screening under current guidelines. By detecting calcification in coronary arteries and identifying early-stage lung cancers simultaneously, this innovative approach addresses the two biggest threats to public health with a single, non-invasive test, a low-dose chest CT scan.

"This is an exciting and creative public health initiative and I'm proud to be a part of it" said Dr. Roxana Mehran, Professor of Interventional Cardiology, Icahn School of Medicine and Director of Women's Health at Mount Sinai. "More women die with cardiovascular disease and lung cancer than all other diseases together. We are committed to changing the status quo for the better" she added.

Heart disease remains the leading cause of death among women, with more than 250,000 women dying annually from coronary heart disease alone. Lung cancer causes about 70,500 deaths annually in women whereas breast cancer results in about 42,000 deaths annually.

"This is a trailblazer event that for the first time brings leaders in preventive cardiology and lung cancer screening under one roof." said Dr. David Yankelevitz, Professor of Radiology, Icahn School of Medicine at Mount Sinai. "An exciting part of this conference is the plethora of AI technologies targeting early detection of heart disease and lung cancer" he added.

The conference brings together world's leaders in cardiology and lung cancer, and will begin with opening remarks by Dr. Harrington, followed by a featured lecture by world-renowned cardiologist Dr. Valentin Fuster, the past president of the American Heart Association and the World Heart Federation.

The complete agenda of the conference is available on www.shapesociety.org.

Medical professionals as well as the public can tune in to the conference via Zoom. Due to limited Zoom space, please register in advance: https://mountsinai.zoom.us/webinar/register/5317226279505/WN_WY02c-_aSluoP4bPH81-GA#/registration

About SHAPE

SHAPE is a non-profit organization dedicated to the eradication of heart attacks. Through advocacy and public awareness campaigns, SHAPE advanced coronary artery calcium (CAC) scan into the national guidelines and helped passed HB1290 in Texas that mandates coverage for CAC scans. SHAPE is currently working with Center for Medicare and Medicaid Services (CMS) to secure national coverage for CAC scans targeting early detection and primary prevention of cardiovascular disease. www.shapesociety.org

About I-ELCAP

I-ELCAP is a global initiative committed to early lung cancer detection and has pioneered research and screening programs using low-dose CT screening to reduce deaths from lung cancer. The program works to promote early-stage diagnosis and improve long-term survival rates. www.I-ELCAP.org

Media Contact

Michell Medellin, SHAPE, 1 3105106004, [email protected], www.vp.org

Twitter

SOURCE SHAPE

Modal title

Dr. Claudia Henschke, founder of I-ELCAP and co-director of the conference.
Dr. Claudia Henschke, founder of I-ELCAP and co-director of the conference.
Dr. Morteza Naghavi, founder of SHAPE and HeartLung.AI and co-director of the conference.
Dr. Morteza Naghavi, founder of SHAPE and HeartLung.AI and co-director of the conference.
Dr. Roxana Mehran, professor of interventional cardiology, Icahn School of Medicine at Mount Sinai, and co-director of the conference.
Dr. Roxana Mehran, professor of interventional cardiology, Icahn School of Medicine at Mount Sinai, and co-director of the conference.
Dr. David Yankelevitz, Professor of Radiology, Icahn School of Medicine at Mount Sinai.
Dr. David Yankelevitz, Professor of Radiology, Icahn School of Medicine at Mount Sinai.
Dr. Claudia Henschke, founder of I-ELCAP and co-director of the conference. Dr. Morteza Naghavi, founder of SHAPE and HeartLung.AI and co-director of the conference. Dr. Roxana Mehran, professor of interventional cardiology, Icahn School of Medicine at Mount Sinai, and co-director of the conference. Dr. David Yankelevitz, Professor of Radiology, Icahn School of Medicine at Mount Sinai.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.